FACIOSCAPULOHUMERAL DYSTROPHY
Clinical trials for FACIOSCAPULOHUMERAL DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new FACIOSCAPULOHUMERAL DYSTROPHY trials appear
Sign up with your email to follow new studies for FACIOSCAPULOHUMERAL DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for FSHD: new drug enters final stage of testing
Disease control Recruiting nowThis phase 3 trial tests an experimental drug called AOC 1020 in 200 adults with facioscapulohumeral muscular dystrophy (FSHD), a genetic condition that causes progressive muscle weakness. Participants receive either the drug or a placebo by IV infusion. The study measures muscle…
Matched conditions: FACIOSCAPULOHUMERAL DYSTROPHY
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Quick walk tests could revolutionize FSH monitoring
Knowledge-focused Recruiting nowThis study looks at whether quick, easy walking tests can replace the current complex and time-consuming exam used to track walking problems in people with facioscapulohumeral muscular dystrophy (FSH). Researchers will compare results from simple tests like the 6-minute walk with…
Matched conditions: FACIOSCAPULOHUMERAL DYSTROPHY
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC